Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease mental depression
Phenotype C0026769|multiple sclerosis
Sentences 58
PubMedID- 23915778 Perfectionism and physical disability predict depression in multiple sclerosis.
PubMedID- 21328292 Pharmacologic treatment of depression in multiple sclerosis.
PubMedID- 26401158 The results obtained from multiple logistic regression analysis showed that the disease course (or for relapsing–remitting ms = 2.36, % 95 ci = 1.14–5.53, p = 0.46), the expanded disability status scale (or for score of 5–8 = 4.88, % 95 ci = 2.51–11.06, p < 0.001) and employment status (or for housewife = 4.75, % 95 ci = 1.55–14.58, p = 0.006) were significant contributing factors to depression in patients with multiple sclerosis.
PubMedID- 22527232 Quality of life and depression in multiple sclerosis patients: longitudinal results of the betaplus study.
PubMedID- 26254948 Objective: to evaluate the efficacy of a telephone-delivered self-management intervention for fatigue, pain, and depression in adults with multiple sclerosis (ms).
PubMedID- 26359900 An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trial.
PubMedID- 24902042 Background: in multiple sclerosis (ms) patients, symptoms of anxiety, depression, pain, and cognitive impairment are highly prevalent and contribute to lower wellbeing.
PubMedID- 22168507 Computerised cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: external pilot trial.
PubMedID- 23244804 Work productivity in relapsing multiple sclerosis: associations with disability, depression, fatigue, anxiety, cognition, and health-related quality of life.
PubMedID- 20204955 We assessed the applicability of ccbt for the treatment of depression in people with multiple sclerosis (ms).
PubMedID- 24501169 Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis.
PubMedID- 19660239 Neuropsychiatric manifestations in multiple sclerosis: correlation of fatigue and depression with disease progression.
PubMedID- 26008945 Selective serotonin-reuptake inhibitors (ssris), commonly administered for depression and anxiety in patients with multiple sclerosis, are associated with qt interval prolongation.
PubMedID- 24406031 We systematically reviewed published controlled trials on the effectiveness of cognitive behavioural therapy (cbt) for the treatment of depression in people with multiple sclerosis.
PubMedID- 25061435 Background: valid assessments are needed in order to identify anxiety and depression in people with multiple sclerosis (ms).
PubMedID- 22860028 A large-scale study of anxiety and depression in people with multiple sclerosis: a survey via the web portal of the uk ms register.
PubMedID- 21432735 depression in multiple sclerosis: reactive or endogenous.
PubMedID- 23783007 Objectives: duloxetine hydrochloride, a dual reuptake inhibitor of serotonin and norepinephrine, was evaluated for its therapeutic efficacy, safety, and tolerability in the treatment of depression in patients with multiple sclerosis (ms).
PubMedID- 23713732 The co-occurrence of pain and depression in adults with multiple sclerosis.
PubMedID- 25580882 Disability identity predicts lower anxiety and depression in multiple sclerosis.
PubMedID- 24559790 Objective: the prevalence of depression in multiple sclerosis (ms) is known to be elevated, but nearly all available studies have estimated period prevalence.
PubMedID- 20809354 The purpose of the study was to evaluate the prevalence of insomnia in multiple sclerosis patients with comorbid depression, associations between psychological symptoms, multiple sclerosis symptoms and insomnia, and to test effects of a 16-week protocol-based psychotherapy intervention for depression on insomnia symptoms.
PubMedID- 24852924 depression in multiple sclerosis: a long-term longitudinal study.
PubMedID- 21585189 depression in multiple sclerosis patients.
PubMedID- 19941048 This study is a secondary analysis from a randomized clinical trial examining telephone-administered psychotherapy treatments for depression among patients with multiple sclerosis (please see mohr et al.
PubMedID- 24926444 [26] forty sessions of ai chi aquatic exercise (ae) program improves pain, spasms, disability, fatigue, depression, and autonomy in patient with multiple sclerosis.
PubMedID- 25933976 Zinc sulphate: a reasonable choice for depression management in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial.
PubMedID- 26445703 Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires.
PubMedID- 23812284 Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis.
PubMedID- 26351621 A brief description of the pathophysiology and effects of depression in patients with multiple sclerosis is also provided.
PubMedID- 25603363 Conclusion our study suggests that coq10 supplementation (500 mg/day) can improve fatigue and depression in patients with multiple sclerosis.
PubMedID- 23460394 Predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year study.
PubMedID- 23379265 Telephone-based physical activity counseling for major depression in people with multiple sclerosis.
PubMedID- 23438712 Objective: the present study examined the relationship between volitional modes of coping (self-regulation, volitional inhibition, and self-control) and depression in individuals with multiple sclerosis.
PubMedID- 23095427 Evaluation of the 9-item patient health questionnaire (phq-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis.
PubMedID- 23754606 Commentary on: predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year study.
PubMedID- 25362584 Effect of neurofeedback training on depression and fatigue in patients with multiple sclerosis.
PubMedID- 25628596 Stroop: msqol, multiple sclerosis quality of life; madrs, montgomery–asberg depression rating scale; mfis, modified fatigue impact scale002e.
PubMedID- 26242758 Magnitude and concurrence of anxiety and depression among attendees with multiple sclerosis at a tertiary care hospital in oman.
PubMedID- 20804269 Comorbid anxiety disorders and treatment of depression in people with multiple sclerosis.
PubMedID- 20007425 depression is common in patients with multiple sclerosis, but to date no studies have explored diffusion tensor imaging indices associated with mood change.
PubMedID- 21995045 In our experiments, we demonstrate the robustness of our method by applying it to map hippocampal atrophy of multiple sclerosis patients with depression on a data set of 109 subjects.
PubMedID- 24453767 Attributional style and depression in multiple sclerosis: the learned helplessness model.
PubMedID- 24653957 Objective: the aim of this study was to investigate the course of alexithymia and its relation with anxiety and depression in patients with multiple sclerosis (ms), over a period of 5 years.
PubMedID- 19822449 Fatigue and depression in children with multiple sclerosis and monophasic variants.
PubMedID- 26223270 depression in multiple sclerosis: the utility of common self-report instruments and development of a disease-specific measure.
PubMedID- 26155372 Sexual dysfunction and depression in individuals with multiple sclerosis: is there a link.
PubMedID- 21948887 Pathogenic mechanisms of depression in multiple sclerosis.
PubMedID- 20663242 Both social support and stress predict depression in multiple sclerosis (ms) patients.
PubMedID- 24574558 Severity of depression in multiple sclerosis also was reported to have association with multiple sclerosis.

Page: 1 2